The ability of p53 to control passage through the cell cycle (in G1 and in G2) and to control apoptosis in response to abnormal proliferative signals and stress including DNA damage is considered to be important for its tumor suppression function.1 p53 is a transcription factor that binds to DNA in a sequence-specific manner to activate transcription of target genes. The consensus DNA binding sequence for p53 consists of two repeats of the 10 bp motif 5′-PuPuPuC(A/T)(A/T)GPyPyPy-3′ separated by 0–13 bp.2 Mutated p53 alleles typically found in tumors encode defective products no longer capable of binding to DNA or activating transcription. There is compelling evidence that the transcriptinal activity of p53 is required for its growth suppressing and tumor suppressing activity.3,4 p53 has also been implicated as a transcriptional repressor;5 however, neither the physiological significance nor the mechanism of p53-mediated repression is known.
The ability of p53 to promote cell cycle arrest is fairly well understood in terms of its ability to transactivate three critical target genes: p21WAF1, GADD45 and 14-3-3σ.6,7,8 p21 induction arrests cells in G1 and prevents S-phase entry while GADD45 and 14-3-3σ control the G2/M transition.9,10 None of these genes appears to be involved in p53-dependent apoptosis.
The pathway through which p53 promotes apoptosis involves transcriptional regulation of target genes as well as transcription-independent functions of p53, possibly reflecting distinct mechanisms of p53 action in different cell types.11,12,13,14,15,16,17,18,19,20 p53-dependent apoptosis is dependent on the Apaf-1/caspase-9 pathway21 and involves mitochondrial cytochrome c release.22 How p53 elicits the release of cytochrome c to promote caspase activation remains elusive. A number of p53-regulated genes containing p53 responsive elements have been identified, and some of these represent potential downstream mediators of p53-dependent apoptosis (Figure 1). These include: Bax,23 CD95 (Fas/APO-1),24,25 Killer/DR5,26 Ei24/PIG8,27,28,29 Noxa,30 PERP,31 Pidd,32 p53AIP1,33 and PUMA.34,35
p53-regulated genes encoding cell surface proteins
Killer/DR526 and CD95 (Fas/APO-1)24,25 two members of the TNF receptor family, are induced by DNA damage in a p53-dependent manner and in some systems seem to be sufficient to induce apoptosis. Both proteins contain a death domain and provide a potential link between DNA damage-mediated activation of p53 and caspase activation. PERP is a plasma membrane protein whose induction by doxorubicin is correlated with activation of the p53-dependent apoptotic pathway in transformed mouse embryo fibroblasts. When overexpressed, PERP was shown to cause cell death in fibroblasts.31
p53-regulated genes encoding mitochondrial proteins
The Bax gene promoter contains a p53-binding site and was shown to be p53 responsive.23 The proapoptotic Bax protein is known to accumulate in mitochondria in response to death signals. Noxa mRNA is induced by ionizing radiation in a p53-dependent manner. It encodes a 103-amino acid protein and contains a BH3 motif that is found on Bcl-2 family members. Noxa localizes to the mitochondria and, like Bax, was shown to interact with anti-apoptotic Bcl-2 family members (Bcl-2, Bcl-XL, Mcl-1) through its BH3 domain. Overexpression of Noxa induces apoptosis in a number of cancer cell lines.30 PUMA (for p53 upregulated modulator of apoptosis) encodes a BH3-containing protein that also localizes to the mitochondria. PUMA protein interacts with Bcl-2 and Bcl-XL through its BH3 domain. PUMA expression inhibits cell growth and rapidly induces apoptosis through a pathway involving cytochrome c release and activation of caspase 3 and 9.34,35 p53AIP1 (for p53-regulated apoptosis-inducing protein 1) protein is located in mitochondria and its overexpression results in growth suppression and apoptosis. The induction of p53AIP1 transcription in response to DNA damage is dependent on phosphorylation of p53 at Ser-46.33
p53-regulated genes encoding cytoplasmic proteins
A number of p53-induced genes (PIGs) may be involved in apoptosis through the generation of reactive oxygen species.28 Ei24/PIG8 was initially isolated from mouse cells undergoing etoposide-induced cell death and later from human cells undergoing apoptosis in response to ectopic expression of p53.27,28 Overexpression of Ei24/PIG8 suppresses cell growth and induces aopoptosis.29 Pidd (for p53 induced protein with a death domain) encodes a protein of 915 amino acids in mice (910 amino acids in humans) and contains seven tandem leucine rich repeats (LRR) in the amino terminus and a death domain in the carboxy terminus. Pidd mRNA is induced by γ-irradiation in a p53-dependent manner and the basal level of Pidd mRNA is dependent on p53 status. Overexpression of Pidd inhibits cell growth in a p53-like manner by inducing apoptosis. Antisense inhibition of Pidd expression attenuated p53-mediated apoptosis suggesting that Pidd expression is required for apoptosis.32 A nearly identical molecule was isolated independently on the basis of its similarity to the death domain of hRIP and named LRDD (leucine repeat death domain containing protein).36
The identification of various proteins with apoptosis potential that act immediately downstream of p53 supports the notion of p53 as an apoptotic regulator and offers hope that elucidation of the p53-dependent apoptosis pathway is attainable. So far, however, no single molecule can be considered to be the principal mediator of p53-dependent apoptosis. This raises the question – why is p53 so prolific? Does this property of p53 betray a level of molecular uncertainty and indecision unworthy of the mighty ‘guardian’ or does it reveal a transcriptional activator's functional perfection?
The following observations may be useful in examining this conundrum.
-
1
The p53-mediated transcriptional response to DNA damage is extremely complex. p53-regulated gene expression patterns differ not only in different cell types but also in response to different induction signals. There is substantial heterogeneity in the kinetics (timing and extent) of gene induction as well as on the dependency on p53 for gene induction. This heterogeneity is seen even in related cell lines derived from the same lineage.37,38 The complexity of the p53 response may reflect the distinct pathways through which p53 can be activated in response to various stimuli.39,40 Selectivity among different p53 target promoters could reflect differences in the affinity of various promoters for p53, such that some are responsive only to high levels of p53 or to certain modified forms of p53.41
-
2
In adult mice exposed to whole body γ-irradiation, cells within certain tissues accumulate p53, and some of these cells undergo p53-dependent apoptosis (splenic and thymic lymphocytes, intestinal crypt cells) while other cells (in the lung, salivary gland, choroid plexus, adrenal gland, kidney) do not undergo apoptosis. Moreover, little or no p53 protein is detected in liver, skeletal muscle and brain. Hence, not all cells that accumulate p53 in vivo in response to DNA damage undergo p53-dependent apoptosis.42,43,44 The restriction of p53-dependent apoptosis to certain tissues is likely related to the finding of selective transactivation of endogenous p53 target genes in different organs from irradiated mice.45
-
3
Transgenic mice with p53-responsive reporter constructs demonstrate that p53 transcriptional activity is tightly controlled in vivo in response to γ-irradiation.46,47 p53-dependent transgene induction is seen in the adult spleen, thymus and intestine as well as in most cells of the early but not late embryo. In general, cells which exhibit the strongest p53 transcriptional response belong to the highly proliferative, relatively undifferentiated compartment and it is these cells which are most sensitive to p53-dependent apoptosis.
-
4
A transcription factor, like p53, will have many targets, and many of these will be codependent on other transcription factors that may or may not be coexpressed with p53. For example, the transcriptional regulation of Bax by p53 requires the cooperation of Sp1 or a Sp1-like factor through a 6 base pair motif (5′-GGGCGT-3′) adjacent to the p53 response element.48
-
5
Lt remains unclear why certain cells undergo apoptosis in response to p53 activation while other cells undergo p53-dependent cell cycle arrest. Differences in response have been attributed to the presence of survival factors in the extracellular environment49,50,5152 and to intrinsic factors including cell type and genotype. For example, normal fibroblasts undergo p53-dependent G1 arrest in response to DNA damage whereas hyperproliferative fibroblasts such as those expressing E1A, c-myc or E2F-1 undergo p53-dependent apoptosis.12,53,54,55,5657 Another model proposes that the level of p53 determines whether a cell undergoes cell cycle arrest or apoptosis; growth arrest occurring at low p53 levels and apoptosis occurring with higher levels of p53.58
-
6
p53 was shown to suppress tumor growth in a transgenic mouse model in which expression of a truncated form of SV40 T antigen (T121 – consisting of the amino-terminal 121 residues of T antigen) is directed to the brain choroid plexus epithelium.59 T121 binds and sequesters Rb but is lacking the p53 binding domain. This transgenic model provides evidence that p53 acts to suppress tumor growth by mediating apoptosis of abnormally proliferating cells in vivo.59 Crossing the TgT121 mice with Bax deficient mice showed an attenuation of p53-induced cell death.60 However, deficiency in Bax resulted in a 50% reduction in apoptosis and accelerated tumor growth threefold whereas deficiency in p53 resulted in 85% reduction in apoptosis and a sevenfold increase in tumor growth rate. These findings suggest that Bax mediates only part of the p53-induced cell death effect. In contrast, p53-dependent apoptosis occurs normally in irradiated thymocytes derived from Bax-deficient or Fas-deficient mice suggesting that Bax and Fas may be more relevant in some cellular contexts than others.61,62,63
Animal studies have played an important role in helping to define p53 as a tumor suppressor and in demonstrating the importance of p53-mediated apoptosis to tumor suppression. Not all tissues in p53-null mice are susceptible to tumor formation and not all tissues in normal mice respond to DNA damage or to abnormal proliferative signals by activating p53 and undergoing p53-dependent apoptosis. Tumor suppression by p53 is likely restricted to certain tissues and it is possible that efficient induction of apoptosis in different cells requires the activation of several apoptotic genes perhaps acting in concert or acting independently. Thus, p53 appears to induce apoptosis by multiple pathways in a manner that is regulated in a cell type and signal-specific fashion.
References
Levine AJ . 1997 Cell 88: 323–331
El-Deiry WS et al. 1992 Nat. Genetics 1: 45–49
Crook T et al. 1994 Cell 79: 817–827
Pietenpol JA et al. 1994 Proc. Natl Acad. Sci. USA 91: 1998–2002
Murphy M et al. 1996 Genes Dev. 10: 2971–2980
El-Deiry WS et al. 1993 Cell 75: 817–825
Kastan MB et al. 1992 Cell 71: 587–597
Hermeking H et al. 1997 Mol. Cell 1: 3–11
Wang XW et al. 1999 Proc. Natl. Acad. Sci. USA 96: 3706–3711
Chan TA et al. 2000 Genes Dev. 14: 1584–1588
Caelles C et al. 1994 Nature 370: 220–223
Wagner AJ et al. 1994 Genes Dev. 8: 2817–2830
Haupt Y et al. 1995 Gene Dev. 9: 2170–2183
Sabbatini P et al. 1995 Genes Dev. 9: 2184–2192
Attardi LD et al. 1996 EMBO J. 15: 3693–3701
Yonish-Rouach E et al. 1996 Oncogene 12: 2197–2205
Zhu J et al. 1998 J. Biol. Chem. 273: 13030–13036
Venot C et al. 1998 EMBO J. 17: 4668–4679
Chao C et al. 2000 EMBO J. 19: 4967–4975
Jimenez GS et al. 2000 Nat. Genetics 26: 37–43
Soengas MS et al. 1999 Science 284: 156–159
Schuler M et al. 2000 J. Biol. Chem. 275: 7337–7342
Miyashita T, Reed JC . 1995 Cell 80: 293–299
Owen-Schaub LB et al. 1995 Mol. Cell. Biol. 15: 3032–3040
Muller M et al. 1998 J. Exp. Med. 188: 2033–2045
Wu GS et al. 1997 Nat. Genetics 17: 141–143
Lehar SM et al. 1996 Oncogene 12: 1181–1187
Polyak K et al. 1997 Nature 389: 300–305
Gu Z et al. 2000 Mol. Cell. Biol. 20: 233–241
Oda E et al. 2000 Science 288: 1053–1058
Attardi LD et al. 2000 Genes Dev. 14: 704–718
Lin Y et al. 2000 Nat. Genetics 26: 124–127
Oka K et al. 2000 Cell 102: 849–862
Yu J et al. 2001 Mol. Cell 7: 673–682
Nakano K, Vousden KH . 2001 Mol. Cell 7: 683–694
Telliez JB et al. 2000 Biochem. Biophys. Acta 1478: 280–288
Yu J et al. 1999 Proc. Natl. Acad. Sci. USA 96: 14517–14522
Zhao R et al. 2000 Genes Dev. 14: 981–993
Giaccia AJ, Kastan MB . 1998 Genes Dev. 12: 2973–2983
Prives C . 1998 Cell 95: 5–8
Resnick-Silverman L et al. 1998 Genes Dev. 12: 2102–2107
Merritt AJ et al. 1994 Cancer Res. 54: 614–617
MacCallum DE et al. 1996 Oncogene 13: 2575–2587
Clarke AR et al. 1994 Oncogene 9: 1767–1773
Bouvard V et al. 2000 Oncogene 19: 649–660
Gottlieb E et al. 1997 EMBO J. 16: 1381–1390
Komarova EA et al. 1997 EMBO J. 16: 1391–1400
Thornborrow EC, Manfredi JJ . 2001 J. Biol Chem. 276: 15598–15608
Yonish-Rouach E et al. 1991 Nature 352: 345–347
Lin Y, Benchimol S . 1995 Mol. Cell. Biol. 15: 6045–6054
Canman CE et al. 1995 Gene Dev. 9: 600–611
Johnson P et al. 1993 Mol. Cell. Biol. 13: 1456–1463
Debbas M, White E . 1993 Genes Dev. 7: 546–554
Lowe SW, Ruley HE . 1993 Genes Dev. 7: 535–545
Hermeking H, Eick D . 1994 Science 265: 2091–2093
Qin XQ et al. 1994 Proc. Natl. Acad. Sci. USA 91: 10918–10922
Wu XW, Levine AJ . 1994 Proc. Natl. Acad. Sci. USA 91: 3602–3606
Chen X et al. 1996 Genes Dev. 10: 2438–2451
Symonds H et al. 1994 Cell 78: 703–711
Yin C et al. 1997 Nature 385: 637–640
Knudson CM et al. 1995 Science 270: 96–99
Fuchs EJ et al. 1997 Cancer Res. 57: 2550–2554
O'Connor L et al. 2000 Cancer Res. 60: 1217–1220
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Benchimol, S. p53-dependent pathways of apoptosis. Cell Death Differ 8, 1049–1051 (2001). https://doi.org/10.1038/sj.cdd.4400918
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.cdd.4400918
This article is cited by
-
Non-POU Domain-Containing Octomer-Binding (NONO) protein expression and stability promotes the tumorigenicity and activation of Akt/MAPK/β-catenin pathways in human breast cancer cells
Cell Communication and Signaling (2023)
-
Antitumor effect of partially purified venom protein from Conus virgo on rat glioma cell line
The Journal of Basic and Applied Zoology (2022)
-
Increased incompatibility of heterologous algal symbionts under thermal stress in the cnidarian-dinoflagellate model Aiptasia
Communications Biology (2022)
-
Relevance of mitochondrial dysfunction in heart disease associated with insulin resistance conditions
Pflügers Archiv - European Journal of Physiology (2022)
-
p53 sensitizes chemoresistant non-small cell lung cancer via elevation of reactive oxygen species and suppression of EGFR/PI3K/AKT signaling
Cancer Cell International (2019)